Tag: Takeda
Innate pharma: The biotech Innate Pharma joins forces with a new behemoth, the Japanese Takeda, for its antibodies
(BFM Bourse) – This agreement provides for an initial payment of $5 million and a potential amount of $410 million. Innate Pharma convinces a new tenor in the pharmaceutical industry.…
Takeda Announces Submission of Corporate Governance Report to Tokyo Stock Exchange
Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO: 4502 / NYSE: TAK) today announced that it has filed its Corporate Governance Report with the Tokyo Stock Exchange (“Tokyo Stock Exchange, TSE”), in…
Takeda receives full response letter from FDA for TAK-721
Takeda Pharmaceutical Company Limited (TSE: 4502 / NYSE: TAK) (“Takeda”) announced today that it has received a Complete Response Letter (CRL) from the United States Food and Drug Administration (FDA)…